2010.10.28 Weekly Broadcast Email
The following updates were made to the CCCWFU CCOP Research Base website for the week of October 25, 2010.
The minutes from the most recent WFU DSMB meeting have been posted on the Adverse Event/DSMB webpage.
97405: (Randomized Study of Soy Protein and Effexor on Vasomotor Symptoms of Men with Prostate Cancer)
The 2010 WFU Continuing Review Approval Letter has been posted to thewebsite.
Reminder: 97509 (A Feasibility Study of Armodafinil for Brain Radiation-Induced Fatigue)
For sites outside of NC, during registration please fax the following items to Cephalon at (610) 883-5566 in order to receive study drug.
- DEA License of Patient's Physician
- Pharmacy License (if pharmacy will be receiving Armodafinil)
- CCOP Shipping Information (Include: name, address, department, etc)
- Curriculum Vitae or Biosketch of Patient's Physician
Announcement: New Study Opens
98110 A Randomized Phase II Dose Finding Study of ArginMax for Its Effect on Erectile Function and Quality of Life in Survivors of Prostate Cancer Previously Treated with Radiotherapy
This study offers one cancer control credit and has 140 accruals available. Visit the CCCWFU CCOP Research Base website for the protocol documents.